Gene · 8038
Papers1,979
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 1,979
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| N7-methylguanosine-related miRNAs predict hepatocellular carcinoma prognosis and immune therapy. | Aging (Albany NY) | 2023 | 37925170 | PubTator, text mining | PubMed |
| Cryo-EM structure of human PAPP-A2 and mechanism of substrate recognition. | Commun Chem | 2023 | 37898658 | PubTator, text mining | PubMed |
| Biomarkers in Systemic Sclerosis: An Overview. | Curr Issues Mol Biol | 2023 | 37886934 | PubTator, text mining | PubMed |
| MiR-135b-5p targets ADAM12 to suppress invasion and accelerate trophoblast apoptosis in preeclampsia. | Placenta | 2023 | 37864886 | PubTator, text mining | PubMed |
| Single-cell profiling reveals immune disturbances landscape and HLA-F-mediated immune tolerance at the maternal-fetal interface in preeclampsia. | Front Immunol | 2023 | 37854606 | PubTator, text mining | PubMed |
| The entanglement of extracellular matrix molecules and immune checkpoint inhibitors in cancer: a systematic review of the literature. | Front Immunol | 2023 | 37854588 | PubTator, text mining | PubMed |
| A new strategy to identify ADAM12 and PDGFRB as a novel prognostic biomarker for matrine regulates gastric cancer via high throughput chip mining and computational verification. | Comput Biol Med | 2023 | 37847945 | PubTator, text mining | PubMed |
| Depletion of slow-cycling PDGFRα+ADAM12+ mesenchymal cells promotes antitumor immunity by restricting macrophage efferocytosis. | Nat Immunol | 2023 | 37798557 | PubTator, text mining | PubMed |
| Super-enhancer-associated SNHG15 cooperating with FOSL1 contributes to bladder cancer progression through the WNT pathway. | Pharmacol Res | 2023 | 37758102 | PubTator, text mining | PubMed |
| Prognostic Impact of FSTL3, ADAM12, and FAT4 in Patients of Colon Cancer: Clinicopathologic Study. | Appl Immunohistochem Mol Morphol | 2023 | 37751246 | PubTator, text mining | PubMed |
| Update on the association of miR-149 rs2292832 C>T polymorphism with gastric cancer risk: A meta-analysis study of gastrointestinal cancers. | Medicine (Baltimore) | 2023 | 37747007 | PubTator, text mining | PubMed |
| Immuno-oncologic signature of malignant transformation in oral squamous cell carcinoma. | Oral Surg Oral Med Oral Pathol Oral Radiol | 2023 | 37739913 | PubTator, text mining | PubMed |
| A pan-cancer analysis of STAT3 expression and genetic alterations in human tumors. | Open Med (Wars) | 2023 | 37724127 | PubTator, text mining | PubMed |
| Identification and verification of plasma protein biomarkers that accurately identify an ectopic pregnancy. | Clin Proteomics | 2023 | 37715129 | PubTator, text mining | PubMed |
| Identification of microRNA editing sites in clear cell renal cell carcinoma. | Sci Rep | 2023 | 37704698 | PubTator, text mining | PubMed |
| Calcium electroporation of esophageal cancer induces gene expression changes: a sub-study of a phase I clinical trial. | J Cancer Res Clin Oncol | 2023 | 37688629 | PubTator, text mining | PubMed |
| From Biomarkers to the Molecular Mechanism of Preeclampsia-A Comprehensive Literature Review. | Int J Mol Sci | 2023 | 37686054 | PubTator, text mining | PubMed |
| Screening for Preeclampsia and Fetal Growth Restriction in the First Trimester in Women without Chronic Hypertension. | J Clin Med | 2023 | 37685649 | PubTator, text mining | PubMed |
| Zika virus targets human trophoblast stem cells and prevents syncytialization in placental trophoblast organoids. | Nat Commun | 2023 | 37684223 | PubTator, text mining | PubMed |
| Identification of Potential Abnormal Methylation-Modified Genes in Coronary Artery Ectasia. | Int J Genomics | 2023 | 37662558 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8038/papers?page=8